Nicholas Avgeropoulos
Neurology · Orlando, FLNPI 1881647378
Payments from drug & device makers
Across 222 payments — averaging $699.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novocure Inc.$113K
- Novocure GmbH$24K
- Incyte Corporation$18K
- AstraZeneca$125
- Biogen$92
- GT Medical Technologies, Inc$48
What the payments were for
- Consulting fees$6,0006%
- Speaking & faculty fees$78,65079%
- Travel & lodging$10,84211%
- Food & beverage$4,0144%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novocure Inc. | 179 | $113,140 |
| Novocure GmbH | 9 | $23,667 |
| Incyte Corporation | 31 | $18,224 |
| AstraZeneca | 1 | $125 |
| Biogen | 1 | $92 |
| GT Medical Technologies, Inc | 1 | $48 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$155,296 in reported general payments places this provider in the 85th percentile of 1,434 neurology providers in Florida.
Other neurology in Orlando
- Ramon Rodriguez CruzOrlando$3.4M
- Mark GoldsteinAtlantis$36.1M
- Derrick RobertsonTampa$27.6M
- Beth SafirsteinHallandale Beach$25.7M
- Michael PfefferMiami$24.5M
- Mark BrodyDelray Beach$20.5M
- Paayal PatelWest Palm Beach$17.3M
- Wendy BondFort Myers$14.7M
- William HoneycuttMaitland$14.1M
- Julie SchwartzbardAventura$13.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.